Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 4
2012 3
2013 7
2014 5
2015 4
2016 5
2017 14
2018 12
2019 19
2020 14
Text availability
Article attribute
Article type
Publication date

Search Results

77 results
Results by year
Filters applied: . Clear all
Page 1
Regulatory T cells as a new therapeutic target for atherosclerosis.
Ou HX, Guo BB, Liu Q, Li YK, Yang Z, Feng WJ, Mo ZC. Ou HX, et al. Acta Pharmacol Sin. 2018 Aug;39(8):1249-1258. doi: 10.1038/aps.2017.140. Epub 2018 Jan 11. Acta Pharmacol Sin. 2018. PMID: 29323337 Free PMC article. Review.
Dorzagliatin monotherapy in Chinese patients with type 2 diabetes: a dose-ranging, randomised, double-blind, placebo-controlled, phase 2 study.
Zhu D, Gan S, Liu Y, Ma J, Dong X, Song W, Zeng J, Wang G, Zhao W, Zhang Q, Li Y, Fang H, Lv X, Shi Y, Tian H, Ji L, Gao X, Zhang L, Bao Y, Lei M, Li L, Zeng L, Li X, Hou X, Zhao Y, Hu T, Ge X, Zhao G, Li Y, Zhang Y, Chen L. Zhu D, et al. Among authors: li y. Lancet Diabetes Endocrinol. 2018 Aug;6(8):627-636. doi: 10.1016/S2213-8587(18)30105-0. Epub 2018 May 4. Lancet Diabetes Endocrinol. 2018. PMID: 29735394 Clinical Trial.
Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial.
Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Nowack C, Kolkhof P, Ferreira AC, Schloemer P, Filippatos G; on behalf of the FIDELIO-DKD study investigators; FIDELIO-DKD study investigators. Bakris GL, et al. Am J Nephrol. 2019;50(5):333-344. doi: 10.1159/000503713. Epub 2019 Oct 25. Am J Nephrol. 2019. PMID: 31655812 Free PMC article.
Role of heterogeneous nuclear ribonucleoprotein K in tumor development.
Chen Y, Zeng Y, Xiao Z, Chen S, Li Y, Zou J, Zeng X. Chen Y, et al. Among authors: li y. J Cell Biochem. 2019 Sep;120(9):14296-14305. doi: 10.1002/jcb.28867. Epub 2019 May 24. J Cell Biochem. 2019. PMID: 31127648
Liraglutide Inhibits the Apoptosis of MC3T3-E1 Cells Induced by Serum Deprivation through cAMP/PKA/β-Catenin and PI3K/AKT/GSK3β Signaling Pathways.
Wu X, Li S, Xue P, Li Y. Wu X, et al. Among authors: li y. Mol Cells. 2018 Mar 31;41(3):234-243. doi: 10.14348/molcells.2018.2340. Epub 2018 Feb 21. Mol Cells. 2018. PMID: 29463067 Free PMC article.
Association of the polymorphisms in FOXO1 gene and diabetic nephropathy risk.
Ma J, Pei Y, Xue P, Wang Y, Bao X, Li Y. Ma J, et al. Among authors: li y. Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):1471-1475. doi: 10.1080/21691401.2019.1601103. Artif Cells Nanomed Biotechnol. 2019. PMID: 30987438
Use of flash glucose-sensing technology in patients with type 2 diabetes treated with liraglutide combined with CSII: a pilot study.
Yao MY, Li LQ, Ma JX, Xue P, Li YK. Yao MY, et al. Braz J Med Biol Res. 2019 Dec 20;53(1):e8652. doi: 10.1590/1414-431X20198652. eCollection 2020. Braz J Med Biol Res. 2019. PMID: 31859911 Free PMC article. Clinical Trial.
Continuous subcutaneous insulin infusion combined with liraglutide reduced glycemic variability and oxidative stress in type 2 diabetes mellitus: a study based on the flash glucose monitoring system.
Li LQ, Yao MY, Ma JX, Xue P, Li YK. Li LQ, et al. Endocr J. 2019 Oct 28;66(10):871-880. doi: 10.1507/endocrj.EJ19-0016. Epub 2019 Jun 27. Endocr J. 2019. PMID: 31243192 Free article. Clinical Trial.
Polyethylene glycol loxenatide injections added to metformin effectively improve glycemic control and exhibit favorable safety in type 2 diabetic patients.
Chen X, Lv X, Yang G, Lu D, Piao C, Zhang X, Jiang H, Xie Y, Yang J, Li X, Li Y, Xiao X, Li Y, Sun L, Zheng S, Cheng Q, Peng Y, Yang W. Chen X, et al. Among authors: li y. J Diabetes. 2017 Feb;9(2):158-167. doi: 10.1111/1753-0407.12397. Epub 2016 Jun 21. J Diabetes. 2017. PMID: 26989888 Clinical Trial.
77 results
Jump to page